申请人:SANKYO COMPANY LIMITED
公开号:EP0621270A1
公开(公告)日:1994-10-26
Constitution: a novel compound represented by general formula (1), wherein R¹ represents -OR³ (R³ being H or alkyl), -NR⁴R⁵ (R⁴ and R⁵ being each H, alkyl or alkoxy), -NHCH(R⁶)COR⁷ (R⁶ being H or alkyl, and R⁷ being alkyl), -NHCH(R⁶)COOR⁸(R⁸ being alkyl) or -NHCH(R⁶)CONR⁹R¹⁰ (R⁹ and R¹⁰ being each H or alkyl, or alternatively NR⁹R¹⁰ being a heterocyclic group as a whole); and R² represents H, alkyl or aralkyl. Effect: since the compound has an inhibitory activity type IV collagenase, it is useful as an inhibitor against vascularization, cancer infiltration or cancer metastasis.
构成:通式(1)代表的新型化合物,其中R¹代表-OR³(R³为H或烷基)、-NR⁴R⁵(R⁴和R⁵各自为H、烷基或烷氧基)、-NHCH(R⁶)COR⁷(R⁶为H或烷基、和 R⁷ 为烷基)、-NHCH(R⁶)COOR⁸(R⁸ 为烷基)或-NHCH(R⁶)CONR⁹R¹⁰(R⁹ 和 R¹⁰ 分别为 H 或烷基,或者 NR⁹R¹⁰ 整体为杂环基团);R² 代表 H、烷基或芳烷基。效果:由于该化合物具有抑制 IV 型胶原酶的活性,因此可用作血管化、癌症浸润或癌症转移的抑制剂。